6-35665261-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP5BP4BA1
The NM_004117.4(FKBP5):c.-19-22418C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.641 in 151,294 control chromosomes in the GnomAD database, including 31,356 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely risk allele (no stars).
Frequency
Genomes: 𝑓 0.64 ( 31356 hom., cov: 28)
Consequence
FKBP5
NM_004117.4 intron
NM_004117.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.257
Genes affected
FKBP5 (HGNC:3721): (FKBP prolyl isomerase 5) The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. This encoded protein is a cis-trans prolyl isomerase that binds to the immunosuppressants FK506 and rapamycin. It is thought to mediate calcineurin inhibition. It also interacts functionally with mature hetero-oligomeric progesterone receptor complexes along with the 90 kDa heat shock protein and P23 protein. This gene has been found to have multiple polyadenylation sites. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PP5
Variant 6-35665261-G-C is Pathogenic according to our data. Variant chr6-35665261-G-C is described in ClinVar as [Likely_risk_allele]. Clinvar id is 1702944.Status of the report is no_assertion_criteria_provided, 0 stars. We mark this variant Likely_pathogenic, oryginal submission is: [Likely_risk_allele].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). . Strength limited to SUPPORTING due to the PP5.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.664 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FKBP5 | NM_004117.4 | c.-19-22418C>G | intron_variant | ENST00000357266.9 | NP_004108.1 | |||
FKBP5 | NM_001145775.3 | c.-19-22418C>G | intron_variant | NP_001139247.1 | ||||
FKBP5 | NM_001145776.2 | c.-19-22418C>G | intron_variant | NP_001139248.1 | ||||
FKBP5 | NM_001145777.2 | c.-19-22418C>G | intron_variant | NP_001139249.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FKBP5 | ENST00000357266.9 | c.-19-22418C>G | intron_variant | 1 | NM_004117.4 | ENSP00000349811 | P1 | |||
FKBP5 | ENST00000536438.5 | c.-19-22418C>G | intron_variant | 1 | ENSP00000444810 | P1 | ||||
FKBP5 | ENST00000539068.5 | c.-19-22418C>G | intron_variant | 1 | ENSP00000441205 | P1 | ||||
FKBP5 | ENST00000542713.1 | c.-19-22418C>G | intron_variant | 2 | ENSP00000442340 |
Frequencies
GnomAD3 genomes AF: 0.641 AC: 96989AN: 151202Hom.: 31340 Cov.: 28
GnomAD3 genomes
AF:
AC:
96989
AN:
151202
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.641 AC: 97044AN: 151294Hom.: 31356 Cov.: 28 AF XY: 0.646 AC XY: 47761AN XY: 73886
GnomAD4 genome
AF:
AC:
97044
AN:
151294
Hom.:
Cov.:
28
AF XY:
AC XY:
47761
AN XY:
73886
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2279
AN:
3478
ClinVar
Significance: Likely risk allele
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Susceptibility to severe depressive disorder Pathogenic:1
Likely risk allele, no assertion criteria provided | case-control | Beijing Key Laboratory of Neuropsychopharmacology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology | Jul 01, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at